Janus Henderson Group’s Tandem Diabetes Care TNDM Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $556K | Hold |
29,811
| – | – | ﹤0.01% | 1894 |
|
2025
Q1 | $575K | Hold |
29,811
| – | – | ﹤0.01% | 1884 |
|
2024
Q4 | $1.07M | Sell |
29,811
-883,730
| -97% | -$31.8M | ﹤0.01% | 1653 |
|
2024
Q3 | $38.7M | Sell |
913,541
-536,634
| -37% | -$22.8M | 0.02% | 437 |
|
2024
Q2 | $58.4M | Sell |
1,450,175
-750,622
| -34% | -$30.2M | 0.03% | 350 |
|
2024
Q1 | $77.9M | Sell |
2,200,797
-376,945
| -15% | -$13.3M | 0.04% | 300 |
|
2023
Q4 | $76.2M | Sell |
2,577,742
-93,489
| -3% | -$2.77M | 0.05% | 297 |
|
2023
Q3 | $55.5M | Buy |
2,671,231
+586,832
| +28% | +$12.2M | 0.04% | 343 |
|
2023
Q2 | $51.2M | Buy |
2,084,399
+790,155
| +61% | +$19.4M | 0.03% | 385 |
|
2023
Q1 | $52.6M | Buy |
1,294,244
+828,534
| +178% | +$33.6M | 0.03% | 368 |
|
2022
Q4 | $20.9M | Sell |
465,710
-451,724
| -49% | -$20.3M | 0.02% | 564 |
|
2022
Q3 | $43.9M | Buy |
917,434
+606,133
| +195% | +$29M | 0.02% | 533 |
|
2022
Q2 | $18.4M | Sell |
311,301
-48,554
| -13% | -$2.87M | 0.01% | 581 |
|
2022
Q1 | $41.8M | Sell |
359,855
-289,472
| -45% | -$33.7M | 0.02% | 549 |
|
2021
Q4 | $97.7M | Sell |
649,327
-197,591
| -23% | -$29.7M | 0.04% | 362 |
|
2021
Q3 | $101M | Buy |
846,918
+15,756
| +2% | +$1.88M | 0.04% | 362 |
|
2021
Q2 | $81M | Buy |
+831,162
| New | +$81M | 0.03% | 431 |
|
2020
Q1 | – | Sell |
-7,330
| Closed | -$437K | – | 1414 |
|
2019
Q4 | $437K | Buy |
7,330
+66
| +0.9% | +$3.94K | ﹤0.01% | 1299 |
|
2019
Q3 | $428K | Sell |
7,264
-78
| -1% | -$4.6K | ﹤0.01% | 1297 |
|
2019
Q2 | $474K | Sell |
7,342
-1,840
| -20% | -$119K | ﹤0.01% | 1273 |
|
2019
Q1 | $583K | Buy |
9,182
+3,473
| +61% | +$221K | ﹤0.01% | 1228 |
|
2018
Q4 | $217K | Sell |
5,709
-1,266
| -18% | -$48.1K | ﹤0.01% | 1310 |
|
2018
Q3 | $299K | Buy |
+6,975
| New | +$299K | ﹤0.01% | 1382 |
|